Thorax 2001;56:1 ( January )

Editorial

Do smoking parents seek the best advice for their asthmatic children?

The first 150 words of the full text of this article appear below.

In this issue of Thorax a further paper from Dundee is published which explores a group of 438 children aged 2-12 years with asthma. In their first paper¹ the authors investigated passive smoke exposure, as measured by salivary cotinine levels, and found that exposure to tobacco smoke was highest where housing conditions were crowded and where several heavy smokers smoked in the same room as the child. In a second paper² the authors reported that the intervention of asking the parents to reduce the exposure of their asthmatic children to tobacco smoke was ineffective.

The latest paper by Crombie et al³ on page 9 investigates how often the 438 asthmatic children were taken to their family practitioners (GPs), either for asthma or non-asthma problems, and relates this to their smoke exposure. Smoke exposure was assessed both by salivary cotinine levels and also by the history of intensity of exposure as judged by . . . [Full text of this article]

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Article

Does passive smoking increase the frequency of health service contacts in children with asthma?

I K Crombie, A Wright, L Irvine, R A Clark, and P W Slane
Thorax 2001 56: 9-12. [Abstract] [Full Text] [PDF]

This article has been cited by other articles:

• Myles, P. R., Hubbard, R. B., Gibson, J. E., Pogson, Z., Smith, C. J. P., McKeever, T. M. (2009). Pneumonia mortality in a UK general practice population cohort. Eur J Public Health 19: 521-526 [Abstract] [Full Text]  
• Lim, W S, Baudouin, S V, George, R C, Hill, A T, Jamieson, C, Le Jeune, I, Macfarlane, J T, Read, R C, Roberts, H J, Levy, M L, Wani, M, Woodhead, M A, Pneumonia Guidelines Committee of the BTS Standard, (2009). BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax 64: iii1-iii55 [Full Text]  
• Sadashivaiah, J.B., Carr, B. (2009). Severe community-acquired pneumonia. Contin Educ Anaesth Crit Care Pain 9: 87-91 [Full Text]  
• Lemyze, M, Salomon, S, Brown, D, Detouche, P, Collet, F (2009). What is the target?. BMJ 338: b1604-b1604 [Full Text]  
• Barker, B, Macfarlane, J, Lim, W S, Douglas, G, Macfarlane, J (2009). Local guidelines for management of adult community acquired pneumonia: a survey of UK hospitals. Thorax 64: 181-181 [Full Text]  
• Low, D. E. MD (2008). Treatment of community-acquired pneumonia. CMAJ 179: 1245-1246 [Full Text]  
• Durrington, H. J, Summers, C. (2008). Recent changes in the management of community acquired pneumonia in adults. BMJ 336: 1429-1433 [Full Text]  
• Barlow, G., Nathwani, D., Myers, E., Sullivan, F., Stevens, N., Duffy, R., Davey, P. (2008). Identifying barriers to the rapid administration of appropriate antibiotics in community-acquired pneumonia. J Antimicrob Chemother 61: 442-451 [Abstract] [Full Text]  
• Bjerre, L. M (2007). Management of community acquired pneumonia. BMJ 335: 1004-1005 [Full Text]  
• Anderson, R., Steel, H. C., Cockeran, R., von Gottberg, A., de Gouveia, L., Klugman, K. P., Mitchell, T. J., Feldman, C. (2007). Comparison of the effects of macrolides, amoxicillin, ceftriaxone, doxycycline, tobramycin and fluoroquinolones, on the production of pneumolysin by Streptococcus pneumoniae in vitro. J Antimicrob Chemother 60: 1155-1158 [Abstract] [Full Text]  
• Valencia, M., Badia, J. R., Cavalcanti, M., Ferrer, M., Agusti, C., Angrill, J., Garcia, E., Mensa, J., Niederman, M. S., Torres, A. (2007). Pneumonia Severity Index Class V Patients With Community-Acquired Pneumonia: Characteristics, Outcomes, and Value of Severity Scores. Chest 132: 515-522 [Abstract] [Full Text]  
• Gorman, S. K, Slavik, R. S, Marin, J. (2007). Corticosteroid Treatment of Severe Community-Acquired Pneumonia. The Annals of Pharmacotherapy 41: 1233-1237 [Abstract] [Full Text]  
• Bont, J., Hak, E., Hoes, A. W., Schipper, M., Schellevis, F. G., Verheij, T. J. M. (2007). A prediction rule for elderly primary-care patients with lower respiratory tract infections. Eur Respir J 29: 969-975 [Abstract] [Full Text]  
• Barlow, G., Nathwani, D., Davey, P. (2007). The CURB65 pneumonia severity score outperforms generic sepsis and early warning scores in predicting mortality in community-acquired pneumonia. Thorax 62: 253-259 [Abstract] [Full Text]  
• Anderson, R., Steel, H. C., Cockeran, R., Smith, A. M., von Gottberg, A., de Gouveia, L., Brink, A., Klugman, K. P., Mitchell, T. J., Feldman, C. (2007). Clarithromycin alone and in combination with ceftriaxone inhibits the production of pneumolysin by both macrolide-susceptible and macrolide-resistant strains of Streptococcus pneumoniae. J Antimicrob Chemother 59: 224-229 [Abstract] [Full Text]  
• Abgueguen, P., Azoulay-Dupuis, E., Noel, V., Moine, P., Rieux, V., Fantin, B., Bedos, J.-P. (2007). Amoxicillin Is Effective against Penicillin-Resistant Streptococcus pneumoniae Strains in a Mouse Pneumonia Model Simulating Human Pharmacokinetics. Antimicrob. Agents Chemother. 51: 208-214 [Abstract] [Full Text]  
• Barlow, G., Nathwani, D., Williams, F., Ogston, S., Winter, J., Jones, M., Slane, P., Myers, E., Sullivan, F., Stevens, N., Duffey, R., Lowden, K., Davey, P. (2007). Reducing door-to-antibiotic time in community-acquired pneumonia: controlled before-and-after evaluation and cost-effectiveness analysis. Thorax 62: 67-74 [Abstract] [Full Text]  
• Espana, P. P., Capelastegui, A., Gorordo, I., Esteban, C., Oribe, M., Ortega, M., Bilbao, A., Quintana, J. M. (2006). Development and Validation of a Clinical Prediction Rule for Severe Community-acquired Pneumonia. Am. J. Respir. Crit. Care Med. 174: 1249-1256 [Abstract] [Full Text]  
• Hopstaken, R M, Coenen, S, Butler, C C, Nelemans, P, Muris, J W M, Rinkens, P E L M, Kester, A D M, Dinant, G J (2006). Prognostic factors and clinical outcome in acute lower respiratory tract infections: a prospective study in general practice. Fam Pract 23: 512-519 [Abstract] [Full Text]  
• Ferech, M., Coenen, S., Malhotra-Kumar, S., Dvorakova, K., Hendrickx, E., Suetens, C., Goossens, H., on behalf of the ESAC Project Group, (2006). European Surveillance of Antimicrobial Consumption (ESAC): outpatient quinolone use in Europe. J Antimicrob Chemother 58: 423-427 [Abstract] [Full Text]  
• Bourke, S J (2006). Interstitial lung disease: progress and problems.. Postgrad. Med. J. 82: 494-499 [Abstract] [Full Text]  
• el Moussaoui, R., de Borgie, C. A J M, van den Broek, P., Hustinx, W. N, Bresser, P., van den Berk, G. E L, Poley, J.-W., van den Berg, B., Krouwels, F. H, Bonten, M. J M, Weenink, C., Bossuyt, P. M M, Speelman, P., Opmeer, B. C, Prins, J. M (2006). Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study.. BMJ 332: 1355-1355 [Abstract] [Full Text]  
• Paul, J. (2006). What is the optimal duration of antibiotic therapy?. BMJ 332: 1358-1358 [Full Text]  
• Nathwani, D., on behalf of Scottish Medicines Consortium (SMC) S, (2006). Antimicrobial prescribing policy and practice in Scotland: recommendations for good antimicrobial practice in acute hospitals. J Antimicrob Chemother 57: 1189-1196 [Abstract] [Full Text]  
• Hoare, Z., Lim, W. S. (2006). Pneumonia: update on diagnosis and management.. BMJ 332: 1077-1079 [Full Text]  
• Ali, M. H., Kalima, P., Maxwell, S. R. J. (2006). Failure to implement hospital antimicrobial prescribing guidelines: a comparison of two UK academic centres. J Antimicrob Chemother 57: 959-962 [Abstract] [Full Text]  
• Littlejohns, P., Chalkidou, K. (2006). Evidence for health policy. Journal of Research in Nursing 11: 110-117  
• Barlow, G. D (2006). Prognostic assessment will be important in flu pandemic.. BMJ 332: 490-491 [Full Text]  
• Capelastegui, A., Espana, P. P., Quintana, J. M., Areitio, I., Gorordo, I., Egurrola, M., Bilbao, A. (2006). Validation of a predictive rule for the management of community-acquired pneumonia. Eur Respir J 27: 151-157 [Abstract] [Full Text]  
• Wedzicha, J A, Howard, E C, Johnston, S L, Mitchell, D M (2005). Thorax Annual Report October 2004-September 2005. Thorax 60: 987-988 [Full Text]  
• Barlow, G, Nathwani, D (2005). Is antibiotic resistance a problem? A practical guide for hospital clinicians. Postgrad. Med. J. 81: 680-692 [Abstract] [Full Text]  
• McLaughlin, C.M., Bodasing, N., Boyter, A.C., Fenelon, C., Fox, J.G., Seaton, R.A. (2005). Pharmacy-implemented guidelines on switching from intravenous to oral antibiotics: an intervention study. QJM 98: 745-752 [Abstract] [Full Text]  
• Menendez, R., Torres, A., Zalacain, R., Aspa, J., Martin-Villasclaras, J. J., Borderias, L., Benitez-Moya, J. M., Ruiz-Manzano, J., de Castro, F. R., Blanquer, J., Perez, D., Puzo, C., Sanchez-Gascon, F., Gallardo, J., Alvarez, C., Molinos, L., on behalf of the NEUMOFAIL Group, (2005). Guidelines for the Treatment of Community-acquired Pneumonia: Predictors of Adherence and Outcome. Am. J. Respir. Crit. Care Med. 172: 757-762 [Abstract] [Full Text]  
• Weiss, K., Tillotson, G. S. (2005). The Controversy of Combination vs Monotherapy in the Treatment of Hospitalized Community-Acquired Pneumonia. Chest 128: 940-946 [Abstract] [Full Text]  
• Little, P., Rumsby, K., Kelly, J., Watson, L., Moore, M., Warner, G., Fahey, T., Williamson, I. (2005). Information Leaflet and Antibiotic Prescribing Strategies for Acute Lower Respiratory Tract Infection: A Randomized Controlled Trial. JAMA 293: 3029-3035 [Abstract] [Full Text]  
• Herth, F., Ernst, A., Becker, H. D. (2005). Endoscopic Drainage of Lung Abscesses: Technique and Outcome. Chest 127: 1378-1381 [Abstract] [Full Text]  
• Wedzicha, J A, Johnston, S L, Mitchell, D M (2004). Thorax annual report: 1 October 2003 to 30 September 2004. Thorax 59: 1012-1015 [Full Text]  
• Paganin, F., Lilienthal, F., Bourdin, A., Lugagne, N., Tixier, F., Genin, R., Yvin, J-L. (2004). Severe community-acquired pneumonia: assessment of microbial aetiology as mortality factor. Eur Respir J 24: 779-785 [Abstract] [Full Text]  
• Baddour, L. M., Yu, V. L., Klugman, K. P., Feldman, C., Ortqvist, A., Rello, J., Morris, A. J., Luna, C. M., Snydman, D. R., Ko, W. C., Chedid, M. B. F., Hui, D. S., Andremont, A., Chiou, C. C. C. (2004). Combination Antibiotic Therapy Lowers Mortality among Severely Ill Patients with Pneumococcal Bacteremia. Am. J. Respir. Crit. Care Med. 170: 440-444 [Abstract] [Full Text]  
• Harnett, S. J., Fraise, A. P., Andrews, J. M., Jevons, G., Brenwald, N. P., Wise, R. (2004). Comparative study of the in vitro activity of a new fluoroquinolone, ABT-492. J Antimicrob Chemother 53: 783-792 [Abstract] [Full Text]  
• Laird, C, Driscoll, P, Wardrope, J (2004). The ABC of community emergency care: 3 Chest pain. Emerg. Med. J. 21: 226-232 [Full Text]  
• Johnson, A. P., Sheppard, C. L., Harnett, S. J., Birtles, A., Harrison, T., Brenwald, N. P., Gill, M. J., Walker, R. A., Livermore, D. M., George, R. C. (2003). Emergence of a fluoroquinolone-resistant strain of Streptococcus pneumoniae in England. J Antimicrob Chemother 52: 953-960 [Abstract] [Full Text]  
• Midulla, F., de Blic, J., Barbato, A., Bush, A., Eber, E, Kotecha, S, Haxby, E, Moretti, C, Pohunek, P, Ratjen, F (2003). Flexible endoscopy of paediatric airways. Eur Respir J 22: 698-708 [Abstract] [Full Text]  
• Ewig, S., Torres, A. (2003). Is Chlamydia pneumoniae an important pathogen in patients with community-acquired pneumonia?. Eur Respir J 21: 741-742 [Full Text]  
• Nathwani, D. (2003). From evidence-based guideline methodology to quality of care standards. J Antimicrob Chemother 51: 1103-1107 [Full Text]  
• Marrie, T.J. (2003). Coxiella burnetii pneumonia. Eur Respir J 21: 713-719 [Abstract] [Full Text]  
• Luna, C. M. (2003). Blood Cultures in Community-Acquired Pneumonia: Are We Ready To Quit?. Chest 123: 977-978 [Full Text]  
• Gopal Rao, G., Mahankali Rao, C. S., Starke, I. (2003). Clostridium difficile-associated diarrhoea in patients with community-acquired lower respiratory infection being treated with levofloxacin compared with {beta}-lactam-based therapy. J Antimicrob Chemother 51: 697-701 [Abstract] [Full Text]  
• (2003). OTHER ARTICLES NOTED (Nov 01 to 18 Oct 02). Evid. Based Nurs. 6: e1-1 [Full Text]  
• Woodhead, M. (2002). Community-acquired pneumonia in Europe: causative pathogens and resistance patterns. Eur Respir J 20: 20S-27s [Abstract] [Full Text]  
• Baudouin, S V (2002). The pulmonary physician in critical care 3: Critical care management of community acquired pneumonia. Thorax 57: 267-271 [Abstract] [Full Text]